IMMP Valuation

Immutep Ltd

Add to Watchlist

Advanced Chart

1.640

-0.02(-1.205%)1D

Overview
Forecast
Valuation
Earnings

IMMP Relative Valuation

IMMP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IMMP is overvalued; if below, it's undervalued.

Historical Valuation

Immutep Ltd (IMMP) is now in the Fair zone, suggesting that its current forward PS ratio of 83.46 is considered Fairly compared with the five-year average of -8.64. The fair price of Immutep Ltd (IMMP) is between 0.59 to 1.77 according to relative valuation methord.

Relative Value

Fair Zone

0.59-1.77

Current Price：1.64

Fair

-6.81

Trailing

Forward

-2.93

EV/EBITDA

Immutep Ltd. (IMMP) has a current EV/EBITDA of -2.93. The 5-year average EV/EBITDA is -6.19. The thresholds are as follows: Strongly Undervalued below -11.17, Undervalued between -11.17 and -8.68, Fairly Valued between -3.70 and -8.68, Overvalued between -3.70 and -1.20, and Strongly Overvalued above -1.20. The current Forward EV/EBITDA of -2.93 falls within the Overvalued range.

-2.95

EV/EBIT

Immutep Ltd. (IMMP) has a current EV/EBIT of -2.95. The 5-year average EV/EBIT is -6.35. The thresholds are as follows: Strongly Undervalued below -12.08, Undervalued between -12.08 and -9.22, Fairly Valued between -3.48 and -9.22, Overvalued between -3.48 and -0.61, and Strongly Overvalued above -0.61. The current Forward EV/EBIT of -2.95 falls within the Overvalued range.

83.46

Immutep Ltd. (IMMP) has a current PS of 83.46. The 5-year average PS is 68.45. The thresholds are as follows: Strongly Undervalued below -6.29, Undervalued between -6.29 and 31.08, Fairly Valued between 105.82 and 31.08, Overvalued between 105.82 and 143.19, and Strongly Overvalued above 143.19. The current Forward PS of 83.46 falls within the Historic Trend Line -Fairly Valued range.

-5.51

P/OCF

Immutep Ltd. (IMMP) has a current P/OCF of -5.51. The 5-year average P/OCF is -8.69. The thresholds are as follows: Strongly Undervalued below -14.51, Undervalued between -14.51 and -11.60, Fairly Valued between -5.79 and -11.60, Overvalued between -5.79 and -2.88, and Strongly Overvalued above -2.88. The current Forward P/OCF of -5.51 falls within the Overvalued range.

-5.15

P/FCF

Immutep Ltd. (IMMP) has a current P/FCF of -5.15. The 5-year average P/FCF is -7.54. The thresholds are as follows: Strongly Undervalued below -12.43, Undervalued between -12.43 and -9.99, Fairly Valued between -5.10 and -9.99, Overvalued between -5.10 and -2.65, and Strongly Overvalued above -2.65. The current Forward P/FCF of -5.15 falls within the Historic Trend Line -Fairly Valued range.

Immutep Ltd (IMMP) has a current Price-to-Book (P/B) ratio of 21.72. Compared to its 3-year average P/B ratio of 8.45 , the current P/B ratio is approximately 157.11% higher. Relative to its 5-year average P/B ratio of 6.63, the current P/B ratio is about 227.47% higher. Immutep Ltd (IMMP) has a Forward Free Cash Flow (FCF) yield of approximately -12.50%. Compared to its 3-year average FCF yield of -10.21%, the current FCF yield is approximately 22.39% lower. Relative to its 5-year average FCF yield of -8.74% , the current FCF yield is about 43.05% lower.

21.72

P/B

Median3y

8.45

Median5y

6.63

-12.50

FCF Yield

Median3y

-10.21

Median5y

-8.74

Competitors Valuation Multiple

The average P/S ratio for IMMP's competitors is 23.72, providing a benchmark for relative valuation. Immutep Ltd Corp (IMMP) exhibits a P/S ratio of 83.46, which is 251.82% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Zhengye Biotechnology Holding Ltd

Loss

317.52M

DRUG.O

Bright Minds Biosciences Inc

Performance Decomposition

Market capitalization of IMMP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of IMMP in the past 1 year is driven by Unknown.